Progression of hearing loss in neurofibromatosis type 2 according to genetic severity

ConclusionsThis is the first description of long ‐term hearing outcomes in a clinical setting across a large heterogeneous cohort of patients with NF2. The results highlight the potential importance and benefit of considering the genetic severity score of patients when undertaking treatment decisions, as well as planning future natural history s tudies.Level of Evidence2cLaryngoscope, 2018

Source: The Laryngoscope - November 19, 2018 Category: ENT & OMF Authors: Beatrice Emmanouil, Rory Houston, Anne May, James D. Ramsden, C. Oliver Hanemann, Dorothy Halliday, Allyson Parry, Samuel Mackeith Tags: Otology/Neurotology Source Type: research